Tianjin, Hangzhou, Jinan and other cities have adjusted premiums and protections, and partially implemented one-stop settlement with basic medical insurance.
Tianjin, Hangzhou, Jinan and other places have launched the "Huimin Insurance" for the new year, adjusting premiums by age, expanding the varieties and coverage of high-cost specialty drugs, simplifying the claims process, and some cities have achieved one-stop settlement with basic medical insurance.
AI-generated summary
"Huiminbao" is the popular name for urban customized commercial medical insurance. It is a supplementary medical insurance jointly guided by local governments and financial regulatory authorities, commercially operated by insurance companies, and connected with basic medical insurance.
CCTV news: "Huiminbao" is the popular name for "urban customized commercial medical insurance". It is a supplementary medical insurance jointly guided by local governments and financial regulatory authorities, commercially operated by insurance companies, and connected with basic medical insurance. Recently, many cities have launched new-year "Benefits for the People" that have added protection and simplified the claims process.
The Tianjin Huimin Insurance, launched not long ago, has changed from last year's uniform 150 yuan for one year to an age-based coverage of 130 yuan per year for 0-17 years old, 140 yuan per year for 18-49 years old, and 150 yuan per year for those 50 years and above, which has reduced the premium for young people. It has also expanded high-cost specialty drugs to 50 types, further enriching the coverage.
Lu Zhenhu, director of the Benefits and Security Department of the Tianjin Municipal Medical Insurance Bureau, said that 70% of the basic medical insurance catalog is covered by medical insurance. If the remaining 30% is paid by the individual, these medicines or consumables or diagnostic and treatment items that were originally purely self-paid are also included in the reimbursement, which further expands the coverage compared with last year.
The basic premium of Xihu Yilianbao, the 2027 "Huimin Insurance" product launched by Hangzhou, is 150 yuan/year, but the premium for children's medical insurance, college students' medical insurance, and new citizens under the age of 18 is only 100 yuan/year, and you can enjoy up to 3.2 million yuan in protection. Compared with previous years, this year's "Huiminbao" focuses on upgrading the group protection of "one elder and one small", Internet outpatient medical protection, etc. Insurance related staff said that if you have some minor headaches and fever, as long as you make a diagnosis and dispense medication on the Internet at a designated hospital, you can directly settle the claim, with no deductible and a reimbursement rate of 80%.
The newly launched "Huiminbao" products in Jinan and other cities continue the characteristics of "low threshold and wide coverage". There are no age restrictions, no occupation restrictions, no household registration restrictions, and no health notification is required for insurance participation. People with pre-existing conditions can be compensated at an agreed ratio. More and more cities have realized one-stop settlement between "Huimin Bao" and basic medical insurance. When patients are discharged from the hospital, they only need to pay the difference after deducting the reimbursements from medical insurance and "Huimin Bao". There is no need to advance all the expenses themselves, and there is no need to go to the insurance company with thick documents to apply for claims afterwards.

Since November 3, the U.S. Centers for Disease Control and Prevention (CDC) has required all international passengers and crew members entering the United States to sign a statement confirming that they have not traveled to or passed through the Democratic Republic of the Congo in the past 21 days to prevent the introduction of the Ebola virus into the United States. Those who do not sign will not be allowed to board the aircraft. No relevant cases have been reported in the United States so far.

Statistics from the Ministry of Health and Welfare show that my country's standardized death rate from lung cancer in 2012 was 21.6 per 100,000 people, a 16.9% decrease from 100 years ago. However, lung cancer still accounted for one-fifth of all cancer deaths in 2012. Xu Peisong, chief physician of the Department of Chest Medicine at Shin Kong Hospital, emphasized that there is almost no discomfort in the early stages of lung cancer. It is recommended that high-risk groups undergo early screening through low-dose computed tomography (LDCT) and improve their living habits to reduce the risk of the disease.
The 2026 National Medical Insurance Imaging AI Image Recognition Competition Awards Ceremony was held in Nanning, Guangxi on the 5th. It was jointly sponsored by the National Medical Insurance Administration and the Guangxi Zhuang Autonomous Region Government. It attracted 1,332 teams from home and abroad to participate, and a total of 193 awards were awarded.
Zhang Ke, director of the National Medical Insurance Administration, said in Nanning, Guangxi, that China will promote China's digital and intelligent medical insurance experience to go global and promote medical AI innovation results to benefit people in all countries. The 2026 National Medical Insurance Imaging AI Image Recognition Competition Award Ceremony was held in Nanning. A total of 1,332 teams from home and abroad participated. Guangxi built a high-quality medical imaging data set of 95,000 cases, promoting the transformation of results to ASEAN.

The General Office of the People's Government of Yunnan Province issued the "Fifteenth Five-Year Plan for National Health in Yunnan Province" to promote the expansion of opening up in the health field, strengthen the construction of border public health systems, support cross-border medical services, and deepen China (Yunnan)'s medical assistance to Uganda.
The medical innovation incubation zone of the 9th China International Import Expo opened in Shanghai on November 5. About 30 medical innovations from around the world were unveiled, covering areas such as brain-computer interfaces and thoracic impedance tomography, demonstrating the attractiveness of the Chinese market in medical technology research and development and clinical applications.